Sandmeyer Prize 2025

Sandmeyer Prize 2025

The Swiss Chemical Society (SCS) awards the F. Hoffmann-La Roche team involved in the commercial manufacturing process of Divarasib, an KRAS G12C inhibitor for cancer treatment